EDGEWELL PERSONAL CARE Co (EPC)
EDGEWELL PERSONAL CARE Co (EPC)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net (loss) income | -10,600 | -65,700 | -30,600 | 56,000 |
| Depreciation and amortization | 19,100 | 21,300 | 23,200 | 65,600 |
| Share-based compensation expense | 5,600 | 3,400 | 5,700 | 18,800 |
| Loss on sale of assets | -1,100 | 1,700 | NaN | -1,700 |
| Impairment charges | 0 | 37,400 | 51,100 | NaN |
| (gain) loss on assets held for sale | 1,600 | -3,800 | NaN | NaN |
| Deferred compensation payments | -1,800 | 2,200 | NaN | -2,400 |
| Deferred income taxes | -38,300 | -900 | -21,200 | -500 |
| Deferred compensation payments | NaN | NaN | -3,100 | NaN |
| Defined benefit settlement loss | NaN | NaN | -1,900 | NaN |
| Other, net | -1,600 | 12,500 | -10,500 | -12,200 |
| Increase (decrease) in accounts receivable | NaN | NaN | 15,300 | NaN |
| Increase (decrease) in inventories | NaN | NaN | -100 | NaN |
| Increase (decrease) in other current assets | NaN | NaN | 2,600 | NaN |
| Increase (decrease) in accounts payable, trade | NaN | NaN | 3,300 | NaN |
| Increase (decrease) in other current liabilities | NaN | NaN | -11,300 | NaN |
| Changes in operating assets and liabilities | -82,400 | 54,800 | NaN | 82,700 |
| Net cash used for operating activities | 54,300 | -125,900 | 74,100 | 44,300 |
| Gross proceeds | 338,900 | NaN | NaN | NaN |
| Capital expenditures | 14,000 | 11,600 | 27,600 | 49,400 |
| Collection of deferred purchase price on accounts receivable sold | 100 | 1,700 | 0 | 5,600 |
| Payment for (proceeds from) other investing activity | 0 | NaN | 0 | 1,500 |
| Net cash provided by (used for) investing activities | 325,000 | -9,900 | -27,600 | -45,300 |
| Cash proceeds from debt with original maturities greater than 90 days | 106,000 | 292,000 | 157,000 | 774,000 |
| Cash payments on debt with original maturities greater than 90 days | 383,000 | 155,000 | 147,000 | 678,000 |
| Proceeds from debt with original maturities of 90 days or less | 2,200 | 2,400 | 6,300 | -800 |
| Repurchase of shares | 15,800 | 0 | 0 | 90,200 |
| Dividends to common shareholders | 7,100 | 7,400 | 6,900 | 22,400 |
| Net financing inflow from the accounts receivable facility | -3,100 | 4,300 | -28,300 | 14,200 |
| Employee shares withheld for taxes | 0 | 2,800 | 100 | 7,400 |
| Other, net | 0 | -100 | -100 | -300 |
| Net cash (used for) provided by financing activities | -300,800 | 133,400 | -19,100 | -10,900 |
| Effect of exchange rate changes on cash | -2,100 | 0 | -1,300 | 2,400 |
| Net decrease in cash and cash equivalents | 76,400 | -2,400 | 26,100 | -9,500 |
| Cash and cash equivalents, beginning of period | 223,300 | 225,700 | 209,100 | NaN |
| Cash and cash equivalents, end of period | 299,700 | 223,300 | 225,700 | NaN |